Tokyo, August 2 , 2024 – Genesis Healthcare Co. will participate in the 69th Congress of the Japan Society of Human Genetics, held in Sapporo, Hokkaido from October 9th to 12th.
Visit our team and our booth to learn about our latest in genomic services, including GenesisPro and GenesisGaia.
In addition, Dr. Koichiro Higasa, Professor and Director of the Institute of Biomedical Research and Innovation, Kansai Medical University, and our team will host a luncheon seminar on October 11th, focusing on harnessing genomic data in R&D through GenesisGaia, our genomic R&D platform powered by A.I.
More information about the 69th Congress of the Japan Society of Human Genetics Japan here.
For press and media inquiries, please contact:
Email: press@genesis-healthcare.jp
About Genesis Healthcare Co.
Celebrating its 20th anniversary, Genesis Healthcare Co. is Japan’s leading genetic testing and research company, servicing medical institutions, corporations, and individuals to benefit from personalized health and precision medicine. Through its patented A.I. driven prediction models, Genesis Healthcare Co. provides advanced genetic testing services, from prevention to diagnostics.
For additional information, please visit:
GenesisGaia and GenesisPro are registered trademarks of Genesis Healthcare Co.
Comments